Moores Director Diane M. Simeone, MD to Lead Large Study of Pancreatic Cysts with Immunovia
|
Dr. Simeone, an expert in pancreatic neoplasms, is collaborating with Immunovia on an NIH-funded project to validate a biomarker test for detecting pancreatic cystic neoplasms that could become cancerous. This test will help determine which patients need surgery and which can be safely monitored to prevent unnecessary procedures and ensure early cancer diagnosis.
|
Adam Engler, PhD Named Inaugural Kenneth Bowles Endowed Chair in the Jacobs School of Engineering, Department of Bioengineering
|
Moores Member Dr. Adam Engler has been named the inaugural Kenneth Bowles Endowed Chair, which honors Kenneth Bowles, a pioneer in computer science. This is one of 18 endowed chairs funded by Irwin and Joan Jacobs to support innovation in engineering. Congratulations, Dr. Engler!
|
Moores Member Receives Robert A. Winn Career Development Award (CDA)
|
Winta T. Mehtsun MD, MPH (Cancer Control Program) has been granted a Winn CDA to support her commitment to increasing diversity in clinical research and advancing health equity. Congratulations, Dr. Mehtsun!
|
2024 Molecular and Cellular Aging Meeting
|
The 2024 Molecular and Cellular Aging Meeting will be held at the Estancia La Jolla Hotel, this September 10–11. To be considered for a short talk and/or reserve a poster slot, please email abstracts to rkapono@sbpdiscovery.org by next Monday, August 19. Registration closes today: Monday, August 12.
|
|
|
Daily Marijuana Use Linked to Increased Risk of Head and Neck Cancer
|
Joseph Califano, MD, Moores Member and Director of the Hanna and Mark Gleiberman Head and Neck Cancer Center, has co-authored an editorial appearing in JAMA Otolaryngology-Head & Neck Surgery, which highlights a study demonstrating that daily marijuana use correlates with an increased risk of head and neck cancer.
|
|
|
Learning Health Systems Science Symposium
|
Thursday, August 15, 2024 | 1:00 p.m. to 5:00 p.m.
Medical Education and Telemedicine Auditorium, UC San Diego
In this inaugural symposium, attendees will learn how UC San Diego Health operates as a learning health system by engaging patients at various stages of care delivery, integrating team-based care and technology to serve patients at the right time and place, and providing opportunities for embedded scientists to contribute to the transformation of healthcare delivery through continuous learning and evidence-based practices.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed)
|
This Notice of Funding Opportunity solicits applications for the RNA Modifications Driving Oncogenesis (RNAMoDO) initiative, which promotes fundamental studies in the emerging area of RNA modifications that underlie the oncogenic process, by addressing the central role of RNA modifications in translational reprogramming of cancer cells. This new initiative will comprise up to five U01 grants, which will be supported by the NCI.
Submission Deadline: November 4, 2024
LOI Deadline: October 5, 2024
|
NCI Small Business Innovation Research (SBIR) Program
|
The NIH and CDC are soliciting proposals from small businesses that possess the research and development expertise to conduct innovative research, which will support NIH and/or CDC mission needs and SBIR program (SBIR) objectives. This program provides early-stage funding to small businesses that are developing cancer technologies in priority areas identified by the NCI.
13 FY2025 SBIR Contract Solicitation Topics:
|
|
|
| The association of perceived cannabis risks and benefits with cannabis use since cancer diagnosis
|
Journal of the National Cancer Institute Monographs
|
Corinne R. McDaniels-Davidson, PhD, MPH (Cancer Control Program [CCP]), Humberto Parada, PhD (CCP), Sandip Patel, MD (Solid Tumor Therapeutics), David Strong, PhD (CCP), and Neal Doran, PhD (CCP)
|
|
|
| Cancer stage and consideration of cannabis use among adult cancer survivors in Southern California
|
Journal of the National Cancer Institute Monographs
|
Matthew Banegas, PhD, MPH, MS (Cancer Control Program [CCP]), Jesse Nodora, DrPH (CCP), Maria Elena Martinez, PhD (CCP), David Strong, PhD (CCP), Neal Doran, PhD (CCP), and Corinne R. McDaniels-Davidson, PhD, MPH (CCP)
|
|
|
| Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers
|
Journal of the National Cancer Institute Monographs
|
Neal Doran, PhD (Cancer Control Program [CCP]) and Corinne R. McDaniels-Davidson, PhD, MPH (CCP)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
TAS-120-205: Phase II Study of Futibatinib 20 mg and 16 mg in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements
|
PI: Adam Burgoyne, MD, PhD
NCT: NCT05727176
|
DF6215-001: A Phase I/Ib, First-In-Human, Multi-Part, Open-Label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of DF6215 in Patients with Advanced (Unresectable, Recurrent, or Metastatic) Solid Tumors |
PI: Gregory Daniels, MD, PhD
NCT: NCT06108479
|
|
|
COMMUNITY OUTREACH & ENGAGEMENT |
Welcome Alexia Barrientos to COE
|
This week COE welcomed new COE liaison Alexia Barrientos, who assisted in outreach efforts at the monthly Jackie Robinson Health Fair, where cancer prevention resources were shared with over 100 community members. Welcome Alexia!
|
Cancer Health Equity Collaborative Mixer at Mujeres Brew House
|
This week COE hosted a networking event attended by over 25 participants representing over a dozen organizations across San Diego County. COE looks forward to hosting more events like this moving forward
|
| |
|
